









Markets
/
Stocks
/
nasdaq-vmd
/

Viemed Healthcare Inc

VMD

6.790USD

+0.270+4.14%

Close 09/18, 16:00（ET）Quotes delayed by 15 min

268.92MMarket Cap

20.98P/E TTM



Viemed Healthcare Inc

6.790

+0.270+4.14%

Overview Company Financials Analysis

TradingKey Stock Score

Overall Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Peer Comparison

TradingKey Stock Score

Currency: USD Updated：2025-09-17

Key Insights

The company's fundamentals are relatively very healthy. Its valuation is considered fairly valued,and institutional recognition is very high. Over the past 30 days, multiple analysts have rated the company as a Buy. The company is performing well in the stock market, with strong fundamentals and technicals supporting the current trend. The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Industry Ranking

17 / 72

Overall Ranking

119 / 4723

Industry

Healthcare Providers & Services

Support & Resistance

No Data

Score Analysis

Current score

Previous score

Analyst Rating

Based on 3 analysts

Buy

Current Rating

13.667

Target Price

+104.29%

Upside Space

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Company Highlights

StrengthsRisks

Viemed Healthcare, Inc. through its subsidiaries, is a provider of home medical equipment (HME) and post-acute respiratory healthcare services in the United States. The Company’s service offerings are focused on effective in-home treatment with clinical practitioners providing therapy and counselling to patients in their homes using cutting edge technologies. The Company’s products and services include Home Medical Equipment, In-home sleep testing, and Healthcare staffing. Home Medical Equipment provides respiratory and other home medical equipment, including home ventilation, bi-level positive airway pressure (BiPAP) and continuous positive airway pressure (CPAP) devices, percussion vests, and other medical equipment. In-home sleep testing provides in home sleep apnea testing services. Healthcare staffing provides healthcare staffing and recruitment services. The Company provides home medical equipment services through its interest in East Alabama HomeMed, LLC (HomeMed).

High Growth

The company's revenue has grown steadily over the past 3 years, averaging 61.53% year-on-year.

High Profit Growth

The company's net income leads the industry, with the latest annual income totaling USD 81.05.

Undervalued

The company’s latest PE is 18.24, at a low 3-year percentile range.

Institutional Selling

The latest institutional holdings are 30.99M shares, decreasing 6.84% quarter-over-quarter.

Held by The Vanguard

Star Investor The Vanguard holds 1.82M shares of this stock.

Higher Market Activity

The company has more investor interest, with a 20-day turnover ratio of 1.12.

Financial Health

Currency: USD Updated：2025-09-17

The company's current financial score is 8.86, which is higher than the Healthcare Providers & Services industry's average of 7.42. Its financial status is robust, and its operating efficiency is high. Its latest quarterly revenue reached 63.06M, representing a year-over-year increase of 14.72%, while its net profit experienced a year-over-year increase of 115.05%.

Score

Industry at a Glance

Previous score

8.86

Change



Financials

9.25

Key Metrics

Cash and cash equivalents

Total assets

Total liabilities

Free cash flow

No Data



Quality of Earnings

10.00

Key Metrics

Total revenue

Operating profit

Total assets

SG&A

No Data



Operational Efficiency

9.23

Key Metrics

Cash flow from operating activities

Income after tax

No Data



Growth Potential

8.41

Key Metrics

Cash flow from operating activities

Total revenue

No Data



Shareholder Returns

7.40

Key Metrics

Free cash flow

No Data

Company Valuation

Currency: USD Updated：2025-09-17

The company’s current valuation score is 5.01, which is higher than the Healthcare Providers & Services industry's average of 2.35. Its current P/E ratio is 18.24, which is 92.87% below the recent high of 35.17 and -51.38% above the recent low of 27.61.

Score

Industry at a Glance

Previous score

4.97

Change

0.04

Valuation Dimensions

P/E

P/B

P/S

P/CF

Industry Ranking 17/72

No Data

Earnings Forecast

Currency: USD Updated：2025-09-17

The company’s current earnings forecast score is 8.00, which is higher than the Healthcare Providers & Services industry's average of 7.58. The average price target for Viemed Healthcare Inc is 15.00, with a high of 15.00 and a low of 11.00.

Score

Industry at a Glance

Previous score

8.00

Change

Support & Resistance

No Data

Analyst Rating

Based on 3 analysts

Buy

Current Rating

13.667

Target Price

+109.61%

Upside Space

Strong Buy

Buy

Hold

Sell

Strong Sell

Peer Comparison

Total

Median

Average

Company name

Ratings

Analysts

Viemed Healthcare Inc

VMD

CVS Health Corp

CVS

HCA Healthcare Inc

HCA

Teladoc Health Inc

TDOC

Tenet Healthcare Corp

THC

Natera Inc

NTRA

...

Financial Forecasting

EPS

Revenue

Net Profit

EBIT

No Data

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Price Momentum

Currency: USD Updated：2025-09-17

The company’s current price momentum score is 6.22, which is lower than the Healthcare Providers & Services industry's average of 6.88. Sideways: Currently, the stock price is trading between the resistance level at 7.15 and the support level at 6.20, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Previous score

6.53

Change

-0.31

Support & Resistance

No Data

Indicators



The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

Indicators

Sell(3)

Neutral(2)

Buy(2)

Indicators

Value

Direction

MACD(12,26,9)

-0.075

Sell

RSI(14)

49.145

Neutral

STOCH(KDJ)(9,3,3)

38.489

Buy

ATR(14)

0.225

Low Volatility

CCI(14)

-68.360

Neutral

Williams %R

70.526

Sell

TRIX(12,20)

-0.092

Sell

StochRSI(14)

100.000

Buy

Moving Average

Sell(2)

Neutral(0)

Buy(4)

Indicators

Value

Direction

MA5

6.708

Buy

MA10

6.752

Buy

MA20

6.911

Sell

MA50

6.743

Buy

MA100

6.782

Buy

MA200

7.284

Sell

Institutional Confidence

Currency: USD Updated：2025-09-17

The company’s current institutional recognition score is 7.00, which is lower than the Healthcare Providers & Services industry's average of 8.03. The latest institutional shareholding proportion is 79.89%, representing a quarter-over-quarter increase of 0.70%. The largest institutional shareholder is The Vanguard, holding a total of 1.82M shares, representing 4.69% of shares outstanding, with 2.46% increase in holdings.

Score

Industry at a Glance

Previous score

7.00

Change

Institutional Shareholding

No Data

Shareholder Activity

Name

Shares Held

Chg %

BlackRock Institutional Trust Company, N.A.

2.51M

+5.84%

Hoyt (Casey)

2.25M

-0.00%

Forager Capital Management, LLC

2.19M

+14.73%

Moore (Michael)

1.90M

The Vanguard Group, Inc.

Star Investors

1.78M

-0.67%

Thrivent Asset Management, LLC

2.71M

-7.96%

Wasatch Global Investors Inc

Star Investors

1.31M

-1.66%

BlackRock Financial Management, Inc.

882.92K

+50.05%

Kent Lake PR LLC

1.23M

-5.65%

Nantahala Capital Management, LLC

932.45K

-0.29%

Risk Assessment

Currency: USD Updated：2025-09-17

The company’s current risk assessment score is 4.64, which is higher than the Healthcare Providers & Services industry's average of 4.17. The company's beta value is 1.32. This indicates that the stock tends to outperform the index during upward trending markets but experiences larger declines during downward trending markets.